Boston Globe reporter Felice Freyer writes about the K. Lisa Yang and Hock E. Tan Center for Molecular Therapeutics in Neuroscience, which was established at the McGovern Institute for Brain Research thanks to a $28 million gift from philanthropist Lisa Yang and MIT alumnus Hock Tan ’75. “The center will develop tools to precisely target the malfunctioning genes and neurons underpinning brain disorders,” writes Freyer.
A gift from alumnus Charles Broderick will enable researchers at MIT and Harvard to investigate how cannabis effects the brain and behavior, reports Felice Freyer for The Boston Globe. Prof. John Gabrieli explains that it has been “incredibly hard” to get funding for marijuana research. “Without the philanthropic boost, it could take many years to work through all these issues,” he notes.
WBUR reporter Carey Goldberg spotlights how a gift from alumnus Charles Broderick is funding research on cannabis and its impacts on the brain. "We were saying, 'Wouldn't it be great to study this?'” says Prof. Myriam Heiman of the need to study the impacts of cannabis. "And then this gift comes along and really is enabling us to do everything we wanted to do."
Boston Globe reporter Martin Finucane writes that MIT researchers have developed sensors that can track dopamine levels in the brain. The sensors could eventually be used to monitor “Parkinson’s patients who receive a treatment called deep brain stimulation,” Finucane explains, adding that the sensors could “help deliver the stimulation only when it’s needed.”
Anne Pycha of Scientific American writes about three new methods that could be used to help detect Parkinson’s disease and enable early intervention. A new typing test developed by MIT researchers could be used to identify individuals with possible signs of Parkinson’s, “by analyzing key hold times (the time required to press and release a key).”
NBC News reporter Maggie Fox writes that MIT researchers have developed a noninvasive brain stimulation technique that could eventually offer relief to patients with diseases like Parkinson’s and epilepsy without requiring surgery. Fox explains that the method allows for sending, “electrical signals deep into the brain without affecting the layers in between.”
MIT researchers have developed a noninvasive method to stimulate specific neurons deep in the brain that could be used to help treat patients with diseases such as Parkinson’s, reports Meredith Wadman for Science. This new method could also allow scientists to “selectively prod deep-brain neurons into action,” explains Wadman.
Writing for Wired, Abigail Beal highlights how MIT researchers have developed a noninvasive technique to trigger reactions in deep brain cells using low frequency electrical signals. “If we could noninvasively stimulate deep regions, without hitting overlying regions, we might be able to help more people because we could stimulate deep regions selectively, without needing surgery,” explains Prof. Ed Boyden.
New York Times reporter Pam Belluck writes that MIT researchers have developed a new, non-invasive deep brain stimulation technique. The technique could be used to help treat, “a range of neurological and psychiatric disorders more cheaply and safely than current approaches,” writes Belluck.
MIT researchers have developed a non-invasive technique for deep brain stimulation, which could be used to help patients with brain diseases, reports Mo Costandi for The Guardian. “Targets for disorders such as depression, Alzheimer’s, PTSD, and so forth, are deep in the brain, and they might be more selectively stimulatable with our method,” says Prof. Ed Boyden.
Washington Post reporter Matt Schudel writes about the impact Prof. Emerita Suzanne Corkin’s work had on our understanding of memory and cognitive disorders. Schudel writes that Corkin, who died on June 4, “made significant contributions to the study of Alzheimer’s disease and Parkinson’s disease, and helped identify regions of the brain affected by degenerative disorders.”
Boston Magazine reporter Jamie Ducharme writes that MIT researchers have developed a new digitized pen that could be used to improve a test that screens for Alzheimer’s and other cognitive impairments. “What the pen does is capture the writing with considerable temporal and spatial accuracy,” Prof. Randall Davis explains.
MIT researchers have developed a new tool that could be used to predict dementia earlier than is currently possible and with greater accuracy, reports Liat Clark for Wired. The researchers hope the new technique could be used to cut down on the number of “hours spent diagnosing, or potentially misdiagnosing, a disorder.”
Alexandra Ossola writes for Popular Science about a computer program created by MIT researchers that can aid in early detection of dementia by analyzing a patient’s drawings. The program “may enable doctors to diagnose patients much more quickly, and to intervene earlier to stave off the onset of cognitive degeneration.”
In a Scientific American podcast, Cynthia Graber examines MIT research showing typing speed can indicate if a person is fatigued and can help diagnose certain diseases. Typing speed could be used as a “safety feature on software programs for night shifts” or could diagnose Parkinson’s “by tracking changes in someone’s ability to manipulate the common keyboard.”